← Product Code FRO · K110062 # MEDIPLUS-FOAM AG; MEDIPLUS-COMFORTFOAM AG; MEDIPLUS-SUPERFOAM AG (K110062) _Medipurpose Pte. , Ltd. · FRO · Sep 1, 2011 · SU · SESE_ **Canonical URL:** https://fda.innolitics.com/device/K110062 ## Device Facts - **Applicant:** Medipurpose Pte. , Ltd. - **Product Code:** FRO - **Decision Date:** Sep 1, 2011 - **Decision:** SESE - **Submission Type:** Traditional - **Device Class:** Class U - **Review Panel:** SU - **Attributes:** Therapeutic ## Intended Use The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings are indicated for exudate absorption and the management of partial to full thickness wounds. Some typical wounds are: - Ulcers (venous, arterial, diabetic) . - Pressure Sores ● - . Donor Sites - Surgical Incisions . - Surgical Excisions . - . Burns (1st and 2nd degree) ## Device Story Multi-layered, sterile, hydrophilic polyurethane (PU) foam wound dressings containing a silver net layer; functions as an antimicrobial barrier and moisture management system. Input: wound exudate; mechanism: mesh facilitates fluid passage into PU foam for absorption; silver ions provide antimicrobial action. MediPlus-ComfortFoam variant includes acrylic adhesive border for fixation. Used in clinical settings for wound care; applied by healthcare providers. Benefits: manages wound moisture, reduces infection risk in partial/full-thickness wounds, and provides antimicrobial protection for 5-7 days. ## Clinical Evidence Bench testing only. Evidence includes biocompatibility testing and antimicrobial effectiveness testing to support substantial equivalence. ## Technological Characteristics Multi-layered hydrophilic PU foam dressing; silver net antimicrobial layer; breathable PU film backing; acrylic adhesive (ComfortFoam variant). Sterile; non-active; no software or electronic components. ## Predicate Devices - Smith & Nephew Inc., Allevyn Ag Dressings, 510(k) # [K063835](/device/K063835.md) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K 110062 Page 1 of 2 SEP - 1 2011 # MediPurpose Pte. Ltd. Traditional 510(k) - MediPlus-Foam™ AG Dressings #### 510(k) Summary | Owner's Information: | MediPurpose, Pte. Ltd.
3850 Holcomb Bridge Road, Suite 350
Norcross, GA 30092 | |----------------------------------------|-------------------------------------------------------------------------------------------------------| | Contact Person: | Julie Stephens, President/Consultant
Regulatory Resources Group, Inc. | | 510(k) Number: | | | Date Prepared: | December 2010 | | Trade/Proprietary Name: | MediPlus-Foam™ AG Dressings
MediPlus-ComfortFoam™ AG Dressings
MediPlus-SuperFoam™ AG Dressings | | Common Name: | Silver Containing Wound Dressing | | Classification Name: | Dressing, wound, drug | | Class: | Unclassified, Pre-Amendment | | Product Code: | FRO | | Legally Marketed
Predicate Devices: | Smith & Nephew Inc., Allevyn Ag Dressings, 510(k) # K063835 | Device Description: . * * The MediPlus-Foam™ AG Dressings product line is a multi-layered, sterile highly absorbing open cell hydrophilic wound dressing composed of a thick soft, smooth elastic and breathable PU foam sandwiched in between a breathable PU film and a silver net layer acting as an ... antimicrobial barrier. The product line is available in different sizes. The MediPlus-SuperFoam™ AG Dressings product line has slightly thicker PU foam and is easier to bend for covering wound areas such as elbows or heels. The MediPlus-ComfortFoam™ AG Dressings is a multi-layered, sterile highly absorbing open cell hydrophilic wound dressing composed of a thick soft, smooth elastic and breathable PU foam sandwiched in between a breathable PU film coated with acrylic adhesive and extends to act as a border adhesive film to allow application without need for secondary dressing or fixation bandage. The silver net layer acts as an antimicrobial barrier. MediPlus-ComfortFoam AG is useful for body sites where applying a secondary dressing or fixation bandage is not practicable or not desired by the user. MediPlus-Foam AG, MediPlus-ComfortFoamAG, andMediPlus-SuperEoam AG Dressingsare used as an antimicrobial barrier for partial and full-thickness wounds such as builts, donor sites and graft recipient sites that are judged to be at risk from infection. The product features include: managing moisture level in the wound environment, controlled silver release, and the product mesh facilitates the passage of fluids/exudates through the dressing into the PU foam for adsorption. The dressings can remain on the wound for five to seven (5-7) days dependent on the amount of wound exudates. Market in the country of the country of the country of the county of the county of the county of the county of the county of the county of the county of the county of the cou {1}------------------------------------------------ ### MediPurpose Pte. Ltd. Traditional 510(k) - MediPlus-Foam™ AG Dressings K 110062 Page 2 of 2 ### 510(k) Summarv #### Intended Use: ್ಕೆ 17 The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings are indicated for exudate absorption and the management of partial to full thickness wounds. Some typical wounds are: - Ulcers (venous, arterial, diabetic) . - Pressure Sores ● - . Donor Sites - Surgical Incisions . - Surgical Excisions . - . Burns (1st and 2nd degree) ### Similarities and Differences of the Proposed Devices to the Predicate Devices: #### Similarities The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings have the same basic technology characteristics for silver containing wound dressings. The features and benefits of using silver containing wound dressings are the same as the predicate and the indications for use are the same. The materials are comparable in that the silver ions are incorporated in the dressing and the plastics used against the wound bed are proven biocompatible. #### Differences The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings utilize some of the same materials, specifically the use of plastics. The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings comply with testing requirements of the recognized biocompatibility standard (see Section C). #### Conclusion: The MediPlus-Foam AG, MediPlus-ComfortFoam AG, and MediPlus-SuperFoam AG Dressings have the same principles of operation, intended use, and technological characteristics as the predicate device. Testing was completed for biocompatibility and antimicrobial effectiveness and the testing reports are contained in the 510(k) documentation (see Section C). {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health & Human Services. The seal features a stylized eagle with three tail feathers, representing the department's commitment to health, services, and people. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the eagle. The seal is black and white. Food and Drug Administration 1 0903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 MediPurpose Pte., Ltd. % Regulatory Resources Group, Inc. Ms. Julie Stephens 111 Laurel Ridge Drive Alpharetta, Georgia 30004 3011 Re: K110062 Trade/Device Name: MediPlus-Foam™ AG Dressings MediPlus-ComfortFoam™ AG Dressings MediPlus-SuperFoam™ AG Dressings Regulatory Class: Unclassified Product Code: FRO Dated: August 01, 2011 Received: August 02, 2011 Dear Ms. Stephens: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a deternination that your device complies with other requirements of the Act {3}------------------------------------------------ Page 2 - Ms. Julie Stephens or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH0ffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours. Cur Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use KJ10062 510(k) Number (if known): Device Name: MediPlus-Foam™ AG Dressings MediPlus-ComfortFoam™ AG Dressings MediPlus-SuperFoam™ AG Dressings Indications for Use: The MediPlus-Foam™ AG, MediPlus-ComfortFoam™ AG, and MediPlus-SuperFoam™ AG Dressings are indicated for exudate absorption and the management of partial to full thickness wounds. Some typical wounds are: - Ulcers (venous, arterial, diabetic) . - Pressure Sores - Donor Sites - Surgical Incisions - Surgical Excisions - Burns (1st and 2nd degree) Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) # (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Daniel Krone keuMKM (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices Page 1 of 1 510(k) Number K110062 --- **Source:** [https://fda.innolitics.com/device/K110062](https://fda.innolitics.com/device/K110062) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com